Corpus 1,272 assessed · 1,173 scored · 643 reproduced ≥75 · 168 flagged ·∅ 74.1/100
← New search

The molecular landscape of sepsis severity in infants: enhanced coagulation, innate immunity, and T cell repression.

Front Immunol · 2024
L1 50/100 3/4
Why this verdict

The main results reproduced, with only marginal, non-material deviations.

Reproduced on the brainbox compute brainarbeit.com
Scoring basis — itemised

Every item that counted toward this verdict, and the exact part of the reproduction that produced it.

Supporting (toward a concern)
Content-critical question only partially held
+2 pts
From: Q5 · Derivability / plausibility 🟡
Content-critical question only partially held
+2 pts
From: Q7 · Core claim 🟡
Content-critical question only partially held
+2 pts
From: Q8 · Severity of the miss (overall human judgment) 🟡
Minor / cosmetic deviation
+1 pts
From: Q3 · Location of the main deviation 🟡
Minor / cosmetic deviation
+1 pts
From: Q6 · Severity of the deviation 🟡
Minor / cosmetic deviation
+1 pts
From: Q2 · Endpoint comparability 🟡
Concordant (toward reproduced)
Code + data deposited & functional
-2 pts
From: Data & code availability Available & functional
Total score +7
✓ What held up
  • Nothing in this column.
What did not (or only partly)
  • 🟡Could not use the authors’ exact input data
  • 🟡Reported values were only indirectly comparable
  • 🟡A deviation arose in the data or preprocessing
  • 🔴A deviation was attributed to the published material
  • 🟡Reported values were not (fully) derivable from the shared data
  • 🟡The deviation was non-trivial in magnitude
  • 🟡The central claim did not (fully) hold under reproduction
  • 🟡Overall, the reproduction showed a material discrepancy
How its reproducibility compares
50/100
Reproducibility score
1.4 SD below mean
vs. all fields · 1173 studies
🎯 Scores higher than 8% of all assessed papers rank 1026 of 1173 scored

A 0–100 reproducibility-quality score from the per-question grades, shown as a z-score: standard deviations above (+) or below (−) the mean of comparable assessments.

Reproduction agent’s raw note

Secondary re-analysis paper. Described well enough ONLY for its deconvolution step, and only as a third-party tool: the paper ships NO analysis code -- the sole resolvable code artifact is the cited ABIS deconvolution Shiny app (github.com/giannimonaco/ABIS, P16). The paper's numbers derive from a custom merge of FIVE GEO datasets (we hold GSE25504, 1 of 5) via COCONUT, with no per-sample group assignment provided, so DEG counts / GO / pseudotime / classifier results (C5-C10) are NOT reproducible from shipped artifacts and were not attempted (documented, not fabricated). What we DID reproduce, faithfully and from public data: ran the cited ABIS microarray signature (rlm robust regression, server.R method) on GSE25504 (GPL6947 Illumina neonatal, 26 infected vs 37 control). All four in-scope directional deconvolution claims that anchor the paper title reproduce with matching direction and high significance: Neutrophils UP (p_BH=1e-07), Monocytes UP (1e-02) = 'enhanced innate immunity'; T Naive/Memory DOWN (2e-08) = 'T cell repression'; naive B DOWN (1e-04). Result = PARTIAL: directional reproduction of the deconvolution claim on the paper's own data with the paper's own cited tool; absolute values not comparable (single dataset vs merged matrix); the preprocessCore quantile step was reimplemented in base R due to a pthread bug on the nodes (core rlm unchanged). NOT attempted: the full 5-dataset COCONUT pipeline, DE, GO, Monocle3, RF, and the 'enhanced coagulation' DE/GO finding -- all lacking shipped code.

💻 Code ↗ 🗄 Data: GSE25504

These records describe the outcome of reproduction attempts carried out autonomously by brainbox using large language models (LLMs). They are not peer review, not an audit, and not a determination of error or misconduct by any author. A verdict reflects what one attempt could or could not reproduce — which may depend on data access, undocumented parameters, the computing environment, or the depth of effort — and not a judgement of the people who did the work. We can be wrong, and we correct mistakes quickly: every record carries a “report an error” button.

Assessment versions

Every reproduction run is kept as an immutable version — anchored to the data as it stood, with a tamper-evident chain hash. A rerun (e.g. after an author updates a deposit) adds a new version; the previous one stays on record.

  1. v1 current initial assessment Score 50
    assessed: 2026-06-15 ⛓ d24f45716913
✎ I am an author of this paper

Updated or fixed a deposit, or is there an erratum? Ask us to re-run the metrics. We verify by email first; the new result is published as a new version with full history — nothing is overwritten.

Reason for the rerun

We email you a confirmation link first. The rerun is an objective re-measurement — it cannot change the verdict in your favour, only ask us to look again.

Provenance — full disclosure

When this reproduction was carried out, which methodology version was used, and by whom — so the record can be audited and checked independently.

Reproduced
2026-06-15
Rubric version
v1.0
Assessed by
🤖 AI curator · claude (ai-curator room) · v1.0 · run #1 2026-06-15
no human curator yet
Last updated
2026-08-05

Provisional, curator- or AI-assessed, and independently checkable. A reproduction outcome states what one attempt could reproduce — not a judgement of the authors.

Deep full-text extraction

Model: opus
Founding hypothesis

Because infant immune responses differ from adults and existing adult-derived sepsis gene signatures may not apply, the study asks what transcriptomic processes characterize sepsis severity and progression to septic shock in infants under 6 months, using a merged multi-study microarray dataset.

Core claims
  • Most published adult/other-cohort sepsis gene signatures have limited utility for infant sepsis; only 2 of 7 achieved >80% accuracy in infants finding
  • Progression to septic shock in infants involves late-stage induction of clotting/coagulation factors, heightened innate immunity, and suppression of adaptive (T cell) functionality finding
  • Pseudotime analysis of individual gene expression profiles reveals a continuum of molecular change forming tight clusters between healthy controls and septic shock concurrent with disease progression finding
  • Disease progression is marked by a transition from adaptive immune cues (e.g., IFN-gamma production) toward greater activation of innate cells and pathways mechanism
  • COCONUT co-normalization removes platform, age, and sex biases while preserving case-control gene expression contrast across merged datasets method
  • A merged multi-transcriptomic infant sepsis dataset (5 studies, n=335) was assembled as a resource for comparative analysis resource
  • Random forest-derived gene modules can classify individuals as Healthy Control or Case method
Experimental setups
Assay System Perturbation Readout Platform
Whole-blood microarray transcriptomics (re-analysis of public datasets) Infant whole blood (<6 months), bacteremia/septic shock/healthy controls, n=335 none (observational disease vs control) Genome-wide gene expression Illumina HumanHT-12 V4.0/V3.0, Codelink 55K, Affymetrix HG-U219/U133 Plus 2.0/Custom HTA (6 platforms)
COCONUT co-normalization and concordance assessment Merged multi-study infant dataset (8466 shared genes) none Normalized log2 expression; housekeeping (ATP6V1B1, GAPDH) and infection genes (CEACAM1, DYSF) COCONUT algorithm (R)
Published gene-signature classification (AUROC/confusion matrix) Merged infant dataset, Case vs Healthy Control none Accuracy, sensitivity, specificity of 7 signatures (SMS, NS, PD25, PD3, SLS, RG, GD) Caret v.3.45 (R)
Pseudotime trajectory analysis Individual subject expression profiles, all groups none Pseudotime clusters/continuum and group-specific marker genes Monocle3 (UMAP, preprocess_cd num_dim=50)
Differential expression and GO over-representation enrichment Pairwise disease groups / pseudotime clusters none DEGs (log2FC>1, BH p.adjust<0.05) and enriched biological processes Wilcoxon rank-sum; clusterProfiler / org.Hs.eg.db
Immune cell type deconvolution Merged infant blood samples (288 samples after filtering) none Relative (22 cell types) and absolute (29 cell types) immune cell proportions CIBERSORTx (LM22) and ABIS Shiny app
Random forest classification of gene modules Merged dataset, Healthy Control vs Case none Feature importance (mean decrease accuracy >0.5%), classification scores, sensitivity/specificity/accuracy MetaboAnalyst 5.0; Caret v.3.45
Key results
  • Only 2 of 7 published sepsis gene signatures reached >80% accuracy in the infant cohort 2 of 7; accuracy >80%
  • COCONUT-normalized data correlated strongly with pre-normalized distribution while reducing platform bias r=0.982
  • Housekeeping genes (ATP6V1B1, GAPDH) showed much smaller variance after normalization while infection genes (CEACAM1, DYSF) remained elevated
  • Sweeney et al. neonatal signature achieved high accuracy for sepsis classification across three cohorts (cited prior work) accuracy=0.9
  • Pseudotime clustering showed bacteremia subjects spread along a continuum fitting Healthy Control-like, Septic Shock-like, or transitory clusters with a shift from adaptive to innate immunity
  • After deconvolution filtering (p<0.05), 288 samples retained and all but one Septic Shock sample dropped, excluding that group from CIBERSORTx analysis 288 samples
Key statistics
  • count 335 (Total subjects in merged dataset (Bacteremia 151, Septic Shock 30, Healthy Controls 154))
  • correlation cor = 0.982, p-value < 2.2e-16 (Pearson correlation of pre vs post COCONUT normalized distributions)
  • mean 18 days (95% CI 15-22) (Overall mean age of subjects)
  • count 59% male / 41% female (Estimated sex distribution (available for 3 of 5 datasets))
  • count 8466 genes (Genes present across all platforms retained for analysis)
  • other median 21,107 (18,947 to 22,296) (Median gene number per platform after probe summarization)
  • other accuracy > 80% (Threshold met by only 2 of 7 published adult/other signatures)
  • pvalue p.adjust < 0.05; log2FC >1 (DEG significance thresholds (Wilcoxon, BH-adjusted))

Statistical methods review

Model: sonnet

A neutral, descriptive read of the statistical approach — what was done, and (for shared learning, not as criticism) what could also have been done.

This study re-analyzed five publicly available whole-blood microarray datasets from infants with bacterial sepsis (total n=335), co-normalizing them with the COCONUT empirical-Bayes algorithm before downstream analyses. Differential gene expression between disease groups (Bacteremia, Septic Shock, Healthy Controls) and pseudotime-derived clusters was assessed with Wilcoxon rank-sum tests, with Benjamini-Hochberg FDR correction applied throughout. Classification performance of published sepsis gene signatures and newly derived gene modules was evaluated via AUROC and a random forest approach, with accuracy, sensitivity, and specificity reported.

Replicationbiological Sample sizeTotal n=335 assembled from five independent public datasets meeting selection criteria; no formal a priori sample size calculation or power analysis described GroupsBacteremia (n=151) vs. Septic Shock (n=30) vs. Healthy Controls (n=154), plus pseudotime-derived clusters Pairingunpaired Randomization/blindingnot stated Dispersionmixed Exact p-valuesno Effect sizesyes Confidence intervalsyes Multiplicity correctionBenjamini-Hochberg (BH) FDR
Statistical tests used
Test Applied to n Assumptions
Two-sided Wilcoxon rank-sum test Pairwise DEG analysis between disease groups (Bacteremia, Septic Shock, Healthy Controls) and between pseudotime clusters Subsets of the merged dataset (Bacteremia n=151, Septic Shock n=30, Healthy Controls n=154; total n=335) not stated
Kruskal-Wallis one-way analysis of variance by ranks Multiple-group comparisons throughout (stated as the default for >2 groups in the Statistical Analysis section) Up to n=335 not stated
Pearson's correlation Assessment of pre- and post-COCONUT normalization distributions (cor=0.982, p<2.2e-16) n=335 not stated
Area under the ROC curve (AUROC) Classification performance of seven published sepsis gene predictor sets applied to the merged infant dataset n=335 na
Random forest classification Classification performance of gene modules and the Garnett marker signature (MetaboAnalyst 5.0) n=335 not stated
Monocle3 topmarker() test (q-value < 0.01, specificity ≥ 0.50) Identification of genes most specifically expressed in each group along the pseudotime trajectory n=335 not stated
Approaches that could also have been used
  • Differential gene expression was identified using a two-sided Wilcoxon rank-sum test applied pairwise across disease groups
    Could also: Linear model-based methods such as limma (with voom or lmFit for microarray data) could also be applied, modeling all group contrasts simultaneously within a single framework — A single linear model framework would handle all pairwise contrasts jointly, naturally propagating variance estimates across groups, and is widely used for microarray meta-analyses; it also provides moderated t-statistics that stabilize estimates for genes with small within-group variance
  • Batch effects across five microarray platforms and studies were addressed with COCONUT co-normalization using control samples
    Could also: ComBat (without requiring matched controls) or surrogate variable analysis (SVA) could also model and remove latent batch structure — ComBat and SVA do not require explicitly matched control samples in every batch, making them applicable when control representation is uneven; SVA additionally estimates unknown sources of variation that may not correspond to known platform labels
  • Gene module and signature classification performance was evaluated using a random forest model with mean decrease accuracy for feature selection
    Could also: Regularized regression approaches such as LASSO or elastic net could also be used to select a sparse gene set while simultaneously fitting a classification model — Regularized regression provides an explicit penalization framework that directly controls model complexity and yields calibrated coefficient estimates, which can facilitate interpretation of gene contributions and generalization to external cohorts
  • The study aggregated five datasets from different platforms and populations into a single merged dataset for joint analysis
    Could also: A formal random-effects meta-analysis of effect sizes computed within each dataset independently could also integrate evidence across studies — A meta-analytic framework explicitly models between-study heterogeneity and yields study-weighted summary effect estimates with associated confidence intervals, which directly quantifies how consistently a finding replicates across the contributing cohorts
  • Age (mean 18 days, 95% CI 15-22) was reported as the primary demographic summary, and sex was available for only three of five datasets
    Could also: Sensitivity analyses stratifying by postnatal age or including age and sex as covariates in the expression model could also be performed — Postnatal age is a well-documented driver of neonatal immune gene expression; explicit covariate adjustment or stratified analyses would help distinguish age-driven expression variation from disease-driven variation, particularly given the wide age range (0-140 days) across contributing datasets
  • Classification performance of seven published gene signatures was compared using AUROC and threshold-based accuracy metrics
    Could also: Confidence intervals for AUROC (e.g., via DeLong's method) and pairwise statistical comparisons of AUROCs across signatures could also be reported — Point-estimate AUROCs alone do not convey uncertainty; CIs and formal pairwise comparisons would clarify whether observed differences in classification performance across the seven signatures are statistically distinguishable given the sample sizes available
Software: COCONUT (R package) · R/caret 3.45 · R/clusterProfiler · Monocle3 · CIBERSORTx · ABIS (Shiny app) · MetaboAnalyst 5.0

Citation network

Where this publication sits in the reproducibility-weighted citation graph — what it is built on, and what is built on it. Citation data from OpenAlex.

Citations
4
Impact: low
Foundation confidence
None of its references are in our reproducibility record yet — its foundation cannot be assessed.
Topics

No assessed neighbours yet — the network grows as more papers are assessed.

Data lineage

The datasets this paper uses (text-mined from the full text via Europe PMC), and which other assessed papers stand on the same data. A shared dataset is a factual link — not a judgement.

GO:0002576 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
also used by 2 papers:
GO:0002283 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
also used by 1 paper:
GO:0002446 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
also used by 1 paper:
GO:0042110 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
also used by 1 paper:
GO:0043312 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
also used by 1 paper:
GO:0050870 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
also used by 1 paper:
GO:0001774 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0002237 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0002269 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0002285 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0002831 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0006413 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0006613 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0006614 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0006778 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0006779 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0007159 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0007596 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0007599 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0030098 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0030099 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0030595 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0031667 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0032102 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0032609 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0032729 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0033014 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0034101 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0042119 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0042129 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0045047 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0045088 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0046651 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0048821 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0050727 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0050817 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0050850 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0050852 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0050863 Gene Ontology (GO) in Supplementary material (http://purl.obolibrary.org/obo/IAO_0000326)
no other assessed paper uses this yet
GO:0055072 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0062197 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0070227 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0070228 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0071216 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0072599 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0097529 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0098754 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0098869 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0140014 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:0150076 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet
GO:1903037 Gene Ontology (GO) in Results (http://purl.org/orb/Results)
no other assessed paper uses this yet

What was reproduced

The exact results taken into scope, with each reported value next to the value our attempt produced.

scope.md — pmid-38817614

Title: The molecular landscape of sepsis severity in infants: enhanced coagulation, innate immunity, and T cell repression. Huang SSY, Toufiq M, Eghtesady P, Van Panhuys N, Garand M. Front Immunol 2024. PMID 38817614 · PMCID PMC11137207 · DOI 10.3389/fimmu.2024.1281111

Nature of the study

This is a secondary re-analysis (no new wet-lab data). The authors merge five public microarray series across six platforms and re-analyze them:

Accession Role in paper
GSE25504 neonatal sepsis (whole blood) — our BRIEF accession
GSE64456 pediatric febrile infants
GSE69686 neonatal
GSE26378 pediatric septic shock
GSE26440 pediatric septic shock

Combined n = 335 → Bacteremia n=151, Septic Shock n=30, Healthy Controls n=154 (per Methods, verbatim sample counts).

Pipeline (as described in Methods):

  1. Per-dataset normalization (RMA / Illumina neqc), log2, probe→gene by mean.
  2. COCONUT cross-platform co-normalization using controls → 8466 common genes.
  3. Differential expression: two-sided Wilcoxon rank-sum, log2FC>1, BH p.adj<0.05.
  4. Immune deconvolution: CIBERSORT (LM22, 22 types) and ABIS (29 types, via the Shiny app https://github.com/giannimonaco/ABIS).
  5. GO enrichment: clusterProfiler (minGSSize=3, FDR<0.05, dispensability 0.4).
  6. Trajectory: Monocle3 (num_dim=50, UMAP) → 3 pseudotime clusters; topmarker().
  7. Classification: random forest via MetaboAnalyst 5.0; published sepsis signatures.

Code availability — CRITICAL CONSTRAINT

The paper provides no repository for its own analysis scripts. The only code artifact cited is the third-party ABIS deconvolution Shiny app (github.com/giannimonaco/ABIS, last push 2020-04-28, no license). All other steps (COCONUT merge, sample→group assignment, Wilcoxon DE, GO, Monocle3, RF) have no shipped code and no per-sample group table. This is the dominant reproducibility gap and is recorded honestly below.

IN SCOPE (will attempt — repo-anchored, P16)

The one step backed by a resolvable code artifact applied to the paper's own data:

  • R1 — ABIS immune-cell deconvolution of GSE25504 (neonatal whole-blood, Illumina HumanHT-12 / GPL6947), infected (bacteremia) vs control, using the cited ABIS microarray signature (sigmatrixMicro.txt) and the exact server.R method (rlm robust regression, quantile-normalize to shipped target, ×100). Pipeline: ABIS (cited repo).
    • Tests the directional claims that anchor the paper's title:
      • neutrophils ↑ in infected vs control ("enhanced innate immunity")
      • T cells (CD4/CD8, naïve) ↓ ("T cell repression")
      • naïve B cells ↓
    • NOTE: the paper reports deconvolution on the merged 5-dataset matrix grouped Bacteremia/Shock/HC, not on GSE25504 alone — so this is a directional / partial reproduction of the deconvolution claim on the paper's own data with the paper's own cited tool, not an exact value match. Graded accordingly.

OUT OF SCOPE (not attempted — reason recorded, per 80/20 + no-completeness rule)

  • Full 5-dataset COCONUT-merged matrix — no shipped code; per-sample group assignment across the 5 series is not provided → cannot reconstruct the exact 335-sample / 3-group matrix the paper's numbers derive from. (docs_insufficient for the merge step.)
  • Wilcoxon DE / DEG counts (Fig 4), GO enrichment (Fig 5/6, Table 2), Monocle3 pseudotime clusters (Fig 3), RF classification & published-signature scoring (Fig 2) — all computed on the merged matrix with no shipped code; the reported values (e.g. "12 DEGs Bacteremia-vs-Shock", "106 DEGs cluster2-vs-3", GO-term counts, classifier accuracy 0.81) are not pinnable to a runnable artifact. Not attempted.
  • CIBERSORT/CIBERSORTx (LM22) — the paper's primary deconvolution, but it is not the cited code and CIBERSORTx is access-gated (registration/license). We run the cited
Figures / tables: Fig 7AFig 7BFig 4Fig 1Fig 2
C1
Reported
Neutrophils significantly increased in Bacteremia vs Healthy Controls (Fig 7A)
Reproduced
ABIS Neutrophils LD UP in infected: median 35.9 vs 13.9 (control), Wilcoxon p_BH=1.1e-07
partial
C2
Reported
Naive B cells lower in Bacteremia vs Healthy Controls (Fig 7A)
Reproduced
ABIS B Naive DOWN in infected: 0.65 vs 3.07, p_BH=9.7e-05
partial
C3
Reported
T cells reduced in Bacteremia ('T cell repression') (Fig 7A)
Reproduced
ABIS T Naive DOWN 18.9 vs 56.4 (p_BH=2e-08); T Memory DOWN 4.7 vs 7.9 (p_BH=8e-03)
partial
C4
Reported
M0 macrophages/monocytes increased in Bacteremia (Fig 7A)
Reproduced
ABIS Monocytes UP 26.1 vs 20.1, p_BH=1.0e-02
partial
C5-C10
Reported
DEG counts, GO terms, Monocle3 pseudotime clusters, RF classifier accuracy (Fig 2-6, Table 2)
Reproduced
NOT ATTEMPTED - no shipped analysis code; merged 5-dataset matrix with no per-sample group table
partial

Assessments & scoring basis

Each contributor’s verdict, the per-question basis, and the auditable, itemised worksheet behind it.

🤖 AI curator · claude (ai-curator room) · v1.0 L1 50/100

An automated assessment. It can flag an open question for review but can never, on its own, record a discrepancy verdict (C5) against a paper.

🟡1. Data identity
🟡2. Endpoint comparability
🟡3. Location of the main deviation
🔴4. Cause of the deviation
🟡5. Derivability / plausibility
🟡6. Severity of the deviation
🟡7. Core claim
🟡8. Severity of the miss (overall human judgment)
Scoring basis — itemised

Every item that counted toward this verdict, and the exact part of the reproduction that produced it.

Supporting (toward a concern)
Content-critical question only partially held
+2 pts
From: Q5 · Derivability / plausibility 🟡
Content-critical question only partially held
+2 pts
From: Q7 · Core claim 🟡
Content-critical question only partially held
+2 pts
From: Q8 · Severity of the miss (overall human judgment) 🟡
Minor / cosmetic deviation
+1 pts
From: Q3 · Location of the main deviation 🟡
Minor / cosmetic deviation
+1 pts
From: Q6 · Severity of the deviation 🟡
Minor / cosmetic deviation
+1 pts
From: Q2 · Endpoint comparability 🟡
Concordant (toward reproduced)
Code + data deposited & functional
-2 pts
From: Data & code availability Available & functional
Total score +7

The four deconvolution claims that anchor the paper's title — innate-immunity activation (neutrophils/monocytes up) and T cell repression (T cells down) — reproduce with matching direction and high significance using the paper's own cited ABIS tool on public GSE25504, with no fabrication signal. The principal limitation is on the authors' side: no analysis code and no per-sample grouping for the merged 5-dataset COCONUT matrix were released, so C5–C10 (DEGs, GO, pseudotime, RF acc=0.813, cor=0.982) are not derivable from shipped artifacts. A secondary, explainable gap is our methodology (single dataset vs merged matrix → only directional, not absolute, comparison; base-R preprocessCore substitution). Overall a solid partial reproduction of the testable core with deviations attributable to missing released code rather than incorrect numbers.

🤝
Reproduced automatically — and fairly

Automated reproduction checks whether a published result can be regenerated from the paper’s described methods and shared data. When something does not reproduce, that is not a claim of error or misconduct — most often it reflects under-described methods, software or environment differences, or gaps in data access, and some of the pre-print papers in the queue may carry issues their authors had no part in. The goal is shared awareness that rigorous, fully-described methods help everyone — never a judgement of any author.

Are you an author? We would genuinely like to hear from you — to clarify the record, add data or code, re-run the pipeline after an accession update, and publish your response right next to the assessment. Everything here is open and auditable.

🚩 Report an error in this record

Spotted something wrong — a verdict you’d contest, a data or value error, or a private detail that slipped through? Tell us, with a short justification. Authors and readers are equally welcome to write in; we review every report.

Prefer email, or the form below not working? Contact us at support@doesitreproduce.com.

Reproduction footprint

claude-opus-4-8

Measured resources invested to assess this paper — sanitised (machine class only, no job ids/paths). Compute = HPC accounting (SLURM); tokens = the AI agent's session.

243.5 k
tokens (I/O) · 17.6 M incl. cache
28 min
runtime · 0.01 CPU-h
1.3 GB
peak RAM
3 (1 failed)
HPC jobs
hummel
machine